Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001493215-26-000063·Orchestra BioMed Holdings, Inc.
Schedule 13D ownership disclosure
Orchestra BioMed Holdings Inc
Common Stock, par value $0.0001 per share · CUSIP: 68572M106
Event date: 2026-02-23
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- RTW Investments, LPReported CIK 0001493215
Shares: 11,942,426.00 · Class: 19.7%
- RTW Master Fund, Ltd.Reported CIK 0001493219
Shares: 5,820,930.00 · Class: 10.0%
- RTW Innovation Master Fund, Ltd.Reported CIK 0001776733
Shares: 4,931,727.00 · Class: 8.4%
- Roderick WongReported CIK 0001493280
Shares: 11,942,426.00 · Class: 19.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493215-26-000063
- Form type
- SCHEDULE 13D/A
- Filer
- Orchestra BioMed Holdings, Inc.
- CIK
- CIK 1814114
- Filed
- Feb 25, 2026
- Reporting period
- Feb 23, 2026
- Description
- Schedule 13D beneficial ownership